Iremofar

Hydroxyzine Hydrochloride, the active ingredient in Iremofar, is a first‑generation antihistamine presented as an oral formulation for oral use. It is employed to relieve itching from allergic skin conditions, reduce anxiety, provide sedation before or after surgical procedures, and control nausea and vomiting. It is also used to manage pruritus associated with urticaria and other hypersensitivity reactions.

GNH USA supplies Iremofar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Hydroxyzine Hydrochloride acts on histamine‑mediated pathways to treat several conditions. - Allergic skin conditions (e.g., urticaria, pruritus): reduces itching and rash. - Anxiety and tension: alleviates symptoms of mild to moderate anxiety. - Sedation before/after surgery: provides calming and sleep‑inducing effects. - Nausea and vomiting: helps control acute episodes of nausea.

Hydroxyzine Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy. - Dry mouth: reduced salivation. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Cardiac arrhythmia: irregular heart rhythm. - Seizures: convulsive episodes in susceptible individuals.

Before prescribing Hydroxyzine Hydrochloride, consider the following safety measures. - Assess hepatic function: adjust use if liver impairment is present. - Evaluate renal function: monitor in patients with severe kidney disease. - Avoid alcohol: concurrent use may enhance sedation. - Use caution in the elderly: increased sensitivity to sedative effects. - Pregnancy and lactation: consult a prescriber before use. - Store at room temperature: keep in the original container, protect from moisture.

Hydroxyzine Hydrochloride can interact with several drug classes.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, opioids): may cause profound sedation. - Alcohol: enhances sedative and respiratory‑depressant effects. - Monoamine oxidase inhibitors: risk of additive anticholinergic effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may increase dry mouth, constipation, and blurred vision. - QT‑prolonging drugs: potential for cardiac rhythm disturbances. - Theophylline: may reduce antihistamine efficacy.